Archives: Agenda

The session will look to look at:

• The impact of wastage in clinical supply chains
• Key aspects of savings and efficiency brought by accurate supply forecasting in clinical trials
• The promise of AI and what it really means
• The RTSM ecosystem and how Supply forecasting fits
• What supply managers and sponsors need to look for when considering this

• Evaluating important criteria to consider when sourcing CMOs
• Considering steps to take when selecting and managing a CMO in early phase trials
• Reviewing changes and additional factors that become relevant as develop into late phase and commercial

• Considering other locations and less saturated markets
• Assessing the differences, benefits and challenges of supplying in these regions
• Discussing considerations for supply models, logistics, regulation and importation

• Identifying opportunities for CDMOs, sponsors, and suppliers using data analytics
• Understanding the clinical trials landscape to facilitate strategic planning
• Addressing issues impacting pharmaceutical supply chains to prepare for and avoid potential disruptions